Reaction

Propofol Infusion Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 697 reports · 27 co-occurring drugs

As of the last recalculation, Propofol Infusion Syndrome appears in 697 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is PROPOFOL (PRR 4,449.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Propofol6184,449.04,525.9
Norepinephrine Bitartrate98236.4238.0
Norepinephrine73227.7229.2
Midazolam150226.2227.5
Midazolam Hydrochloride156222.6223.9
Magnesium Sulfate In Water For3893.994.2
Magnesium Sulfate Heptahydrate3892.192.3
Magnesium Sulfate3891.992.2
Valproic Acid6567.868.0
Phenytoin4162.362.4
Clobazam4761.661.7
Lacosamide6153.653.6
Phenobarbital2451.251.3
Rocuronium Bromide1949.549.6
Oxcarbazepine4038.939.0
Levetiracetam In Sodium Chloride8838.738.7
Levetiracetam Oral8838.738.7
Levetiracetam Injection8838.738.7
Sevoflurane1036.436.5
Fentanyl9432.832.8
Ceftriaxone3432.532.5
Brivaracetam930.330.3
Ceftriaxone Sodium3528.628.7
Levetiracetam10226.526.6
Dalteparin Sodium925.725.7
Remdesivir818.118.1
Amikacin1017.717.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.